

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ATP synthesis coupled proton transport (GO:0015986) | 6.30362408 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.30362408 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.11593459 |
| 4 | viral transcription (GO:0019083) | 5.67401015 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 5.65686569 |
| 6 | translational termination (GO:0006415) | 5.51549145 |
| 7 | ribosomal small subunit biogenesis (GO:0042274) | 5.40283639 |
| 8 | maturation of SSU-rRNA (GO:0030490) | 5.17731889 |
| 9 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.07066606 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 4.97835551 |
| 11 | translational elongation (GO:0006414) | 4.97203250 |
| 12 | protein targeting to ER (GO:0045047) | 4.95298167 |
| 13 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.94570508 |
| 14 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.94570508 |
| 15 | NADH dehydrogenase complex assembly (GO:0010257) | 4.94570508 |
| 16 | protein complex biogenesis (GO:0070271) | 4.89835236 |
| 17 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.87747896 |
| 18 | ribosomal large subunit biogenesis (GO:0042273) | 4.74307629 |
| 19 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.71719636 |
| 20 | protein localization to endoplasmic reticulum (GO:0070972) | 4.70611184 |
| 21 | respiratory electron transport chain (GO:0022904) | 4.63568055 |
| 22 | electron transport chain (GO:0022900) | 4.60522169 |
| 23 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.52018603 |
| 24 | DNA deamination (GO:0045006) | 4.50882770 |
| 25 | viral life cycle (GO:0019058) | 4.14882957 |
| 26 | cellular protein complex disassembly (GO:0043624) | 4.11872425 |
| 27 | chaperone-mediated protein transport (GO:0072321) | 4.11453052 |
| 28 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.01885254 |
| 29 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.98825266 |
| 30 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.98278723 |
| 31 | translation (GO:0006412) | 3.97052202 |
| 32 | translational initiation (GO:0006413) | 3.96257797 |
| 33 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.88692649 |
| 34 | behavioral response to nicotine (GO:0035095) | 3.83458267 |
| 35 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.79560747 |
| 36 | termination of RNA polymerase III transcription (GO:0006386) | 3.79560747 |
| 37 | respiratory chain complex IV assembly (GO:0008535) | 3.69948936 |
| 38 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.64170461 |
| 39 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.64170461 |
| 40 | protein neddylation (GO:0045116) | 3.62610575 |
| 41 | cellular component biogenesis (GO:0044085) | 3.61010767 |
| 42 | ATP biosynthetic process (GO:0006754) | 3.59659612 |
| 43 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.58371541 |
| 44 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.54488028 |
| 45 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.52936229 |
| 46 | proteasome assembly (GO:0043248) | 3.43586548 |
| 47 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.40233112 |
| 48 | protein complex disassembly (GO:0043241) | 3.37648002 |
| 49 | cytochrome complex assembly (GO:0017004) | 3.32233928 |
| 50 | GTP biosynthetic process (GO:0006183) | 3.31645516 |
| 51 | protein targeting to membrane (GO:0006612) | 3.26645957 |
| 52 | platelet dense granule organization (GO:0060155) | 3.23006413 |
| 53 | macromolecular complex disassembly (GO:0032984) | 3.22443128 |
| 54 | negative regulation of mast cell activation (GO:0033004) | 3.21512738 |
| 55 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.18284955 |
| 56 | hydrogen ion transmembrane transport (GO:1902600) | 3.16896257 |
| 57 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.14589581 |
| 58 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.11732283 |
| 59 | aldehyde catabolic process (GO:0046185) | 3.09034767 |
| 60 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.07826552 |
| 61 | kynurenine metabolic process (GO:0070189) | 3.07365417 |
| 62 | deoxyribose phosphate catabolic process (GO:0046386) | 3.02515026 |
| 63 | protein targeting to mitochondrion (GO:0006626) | 3.00502020 |
| 64 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.00376313 |
| 65 | rRNA modification (GO:0000154) | 3.00314814 |
| 66 | mRNA catabolic process (GO:0006402) | 2.98492752 |
| 67 | proton transport (GO:0015992) | 2.96351527 |
| 68 | GPI anchor metabolic process (GO:0006505) | 2.95664656 |
| 69 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.94956479 |
| 70 | deoxyribonucleotide catabolic process (GO:0009264) | 2.94425365 |
| 71 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.93736073 |
| 72 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.92011128 |
| 73 | hydrogen transport (GO:0006818) | 2.90838599 |
| 74 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.90766778 |
| 75 | rRNA processing (GO:0006364) | 2.90722080 |
| 76 | GPI anchor biosynthetic process (GO:0006506) | 2.90494181 |
| 77 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.89900415 |
| 78 | signal peptide processing (GO:0006465) | 2.88830202 |
| 79 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.88555300 |
| 80 | ubiquinone biosynthetic process (GO:0006744) | 2.86959218 |
| 81 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.86076321 |
| 82 | rRNA metabolic process (GO:0016072) | 2.84816923 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 2.83526937 |
| 84 | UTP biosynthetic process (GO:0006228) | 2.82555793 |
| 85 | base-excision repair, AP site formation (GO:0006285) | 2.81301345 |
| 86 | protein-cofactor linkage (GO:0018065) | 2.81020607 |
| 87 | RNA catabolic process (GO:0006401) | 2.79681516 |
| 88 | establishment of protein localization to mitochondrion (GO:0072655) | 2.78680157 |
| 89 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.78154010 |
| 90 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.78012211 |
| 91 | UTP metabolic process (GO:0046051) | 2.75701983 |
| 92 | oxidative phosphorylation (GO:0006119) | 2.72771718 |
| 93 | protein localization to mitochondrion (GO:0070585) | 2.72310089 |
| 94 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.72134109 |
| 95 | pseudouridine synthesis (GO:0001522) | 2.68765321 |
| 96 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.68335042 |
| 97 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.68335042 |
| 98 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.68335042 |
| 99 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.67286630 |
| 100 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.66147199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.31243087 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.23409190 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.08790345 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.75192988 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.46023412 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.45548722 |
| 7 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.16826596 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.08248971 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.98788841 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.84685309 |
| 11 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.77855363 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.54942801 |
| 13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.43896979 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.34268174 |
| 15 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.25191970 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.23369545 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.14891497 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.05801831 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.04871969 |
| 20 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.98302544 |
| 21 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.90551195 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.90212948 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88400854 |
| 24 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.87151419 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.83927878 |
| 26 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.81666679 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.72975037 |
| 28 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.71813781 |
| 29 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.69466586 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.68232859 |
| 31 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.60119619 |
| 32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.47938624 |
| 33 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.47013107 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44649920 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.43892347 |
| 36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.43673494 |
| 37 | EWS_26573619_Chip-Seq_HEK293_Human | 1.43057799 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.40856867 |
| 39 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.37199126 |
| 40 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.37104430 |
| 41 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.34555593 |
| 42 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.33972633 |
| 43 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.33014223 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31977713 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.30397808 |
| 46 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.26648489 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.26005823 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25229955 |
| 49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24281446 |
| 50 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.23560700 |
| 51 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22947112 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22016009 |
| 53 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.21681139 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21178749 |
| 55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20998451 |
| 56 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19852388 |
| 57 | AR_20517297_ChIP-Seq_VCAP_Human | 1.18833751 |
| 58 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.18392175 |
| 59 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.17797349 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.17797349 |
| 61 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16945213 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14172266 |
| 63 | NCOR_22424771_ChIP-Seq_293T_Human | 1.13817268 |
| 64 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.13739312 |
| 65 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.13037502 |
| 66 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.11990580 |
| 67 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11276763 |
| 68 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11075318 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.08459921 |
| 70 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07722065 |
| 71 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03447584 |
| 72 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.03171131 |
| 73 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.02980730 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02934848 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02934848 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02915739 |
| 77 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.01679230 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01506983 |
| 79 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.01400109 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01390557 |
| 81 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99947187 |
| 82 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97832369 |
| 83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97573388 |
| 84 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96663525 |
| 85 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.96302880 |
| 86 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.95269689 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94546930 |
| 88 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94166080 |
| 89 | ERA_21632823_ChIP-Seq_H3396_Human | 0.93523717 |
| 90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91599463 |
| 91 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.91482748 |
| 92 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90348904 |
| 93 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.89625435 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 0.89489087 |
| 95 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.88751348 |
| 96 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.88341304 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86956163 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86864969 |
| 99 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86512038 |
| 100 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86512038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 6.02111832 |
| 2 | MP0006292_abnormal_olfactory_placode | 3.31480751 |
| 3 | MP0003646_muscle_fatigue | 3.05551044 |
| 4 | MP0002163_abnormal_gland_morphology | 2.65166519 |
| 5 | MP0000372_irregular_coat_pigmentation | 2.62463279 |
| 6 | MP0005671_abnormal_response_to | 2.30556967 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.25497785 |
| 8 | MP0002102_abnormal_ear_morphology | 2.23226152 |
| 9 | MP0004142_abnormal_muscle_tone | 2.14469076 |
| 10 | MP0004147_increased_porphyrin_level | 2.04612251 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.03636512 |
| 12 | MP0003787_abnormal_imprinting | 2.03576184 |
| 13 | MP0006276_abnormal_autonomic_nervous | 1.98023389 |
| 14 | MP0006072_abnormal_retinal_apoptosis | 1.89074646 |
| 15 | MP0008872_abnormal_physiological_respon | 1.87803672 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 1.82979559 |
| 17 | MP0001835_abnormal_antigen_presentation | 1.81209466 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 1.79964967 |
| 19 | MP0005645_abnormal_hypothalamus_physiol | 1.79394754 |
| 20 | MP0008877_abnormal_DNA_methylation | 1.78796353 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 1.78555046 |
| 22 | MP0002638_abnormal_pupillary_reflex | 1.77823890 |
| 23 | MP0008058_abnormal_DNA_repair | 1.76671152 |
| 24 | MP0005379_endocrine/exocrine_gland_phen | 1.70246537 |
| 25 | MP0003186_abnormal_redox_activity | 1.70057666 |
| 26 | MP0003880_abnormal_central_pattern | 1.66318925 |
| 27 | MP0005084_abnormal_gallbladder_morpholo | 1.58133911 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.47224598 |
| 29 | MP0005389_reproductive_system_phenotype | 1.46717477 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.45800167 |
| 31 | MP0001905_abnormal_dopamine_level | 1.44646164 |
| 32 | MP0002160_abnormal_reproductive_system | 1.42496457 |
| 33 | MP0003123_paternal_imprinting | 1.41709336 |
| 34 | MP0009764_decreased_sensitivity_to | 1.37668647 |
| 35 | MP0001764_abnormal_homeostasis | 1.36121683 |
| 36 | MP0004885_abnormal_endolymph | 1.32919319 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.32349554 |
| 38 | MP0002938_white_spotting | 1.31570159 |
| 39 | MP0003011_delayed_dark_adaptation | 1.30197750 |
| 40 | MP0001485_abnormal_pinna_reflex | 1.25569533 |
| 41 | MP0000631_abnormal_neuroendocrine_gland | 1.25008132 |
| 42 | MP0002095_abnormal_skin_pigmentation | 1.22498622 |
| 43 | MP0009046_muscle_twitch | 1.21664983 |
| 44 | MP0003718_maternal_effect | 1.20481927 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.18870859 |
| 46 | MP0002272_abnormal_nervous_system | 1.17515049 |
| 47 | MP0002006_tumorigenesis | 1.15587875 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.14949490 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.14820490 |
| 50 | MP0001968_abnormal_touch/_nociception | 1.12809906 |
| 51 | MP0001529_abnormal_vocalization | 1.12807900 |
| 52 | MP0002234_abnormal_pharynx_morphology | 1.12749976 |
| 53 | MP0001919_abnormal_reproductive_system | 1.12501356 |
| 54 | MP0005253_abnormal_eye_physiology | 1.11047830 |
| 55 | MP0003121_genomic_imprinting | 1.08443950 |
| 56 | MP0001293_anophthalmia | 1.05907808 |
| 57 | MP0008789_abnormal_olfactory_epithelium | 1.05034300 |
| 58 | MP0003693_abnormal_embryo_hatching | 1.04745579 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.04617908 |
| 60 | MP0003786_premature_aging | 1.04392409 |
| 61 | MP0001970_abnormal_pain_threshold | 1.00316945 |
| 62 | MP0003195_calcinosis | 0.99070205 |
| 63 | MP0009745_abnormal_behavioral_response | 0.99020880 |
| 64 | MP0009785_altered_susceptibility_to | 0.97891598 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 0.97216500 |
| 66 | MP0002736_abnormal_nociception_after | 0.96422125 |
| 67 | MP0001800_abnormal_humoral_immune | 0.94789836 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 0.93894288 |
| 69 | MP0003878_abnormal_ear_physiology | 0.93894288 |
| 70 | MP0000049_abnormal_middle_ear | 0.92856434 |
| 71 | MP0005195_abnormal_posterior_eye | 0.92015408 |
| 72 | MP0005174_abnormal_tail_pigmentation | 0.91244187 |
| 73 | MP0002148_abnormal_hypersensitivity_rea | 0.91124036 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 0.88968658 |
| 75 | MP0002876_abnormal_thyroid_physiology | 0.87100344 |
| 76 | MP0002733_abnormal_thermal_nociception | 0.86596887 |
| 77 | MP0005360_urolithiasis | 0.85574581 |
| 78 | MP0001440_abnormal_grooming_behavior | 0.84344556 |
| 79 | MP0004043_abnormal_pH_regulation | 0.81581064 |
| 80 | MP0002210_abnormal_sex_determination | 0.80322823 |
| 81 | MP0002557_abnormal_social/conspecific_i | 0.78293675 |
| 82 | MP0005332_abnormal_amino_acid | 0.77305000 |
| 83 | MP0005387_immune_system_phenotype | 0.76210444 |
| 84 | MP0001790_abnormal_immune_system | 0.76210444 |
| 85 | MP0010094_abnormal_chromosome_stability | 0.74285529 |
| 86 | MP0001119_abnormal_female_reproductive | 0.72749112 |
| 87 | MP0003638_abnormal_response/metabolism_ | 0.71888870 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.71069115 |
| 89 | MP0002735_abnormal_chemical_nociception | 0.70448874 |
| 90 | MP0002723_abnormal_immune_serum | 0.70337498 |
| 91 | MP0001501_abnormal_sleep_pattern | 0.70171371 |
| 92 | MP0002752_abnormal_somatic_nervous | 0.67980848 |
| 93 | MP0002572_abnormal_emotion/affect_behav | 0.67247376 |
| 94 | MP0001929_abnormal_gametogenesis | 0.66422284 |
| 95 | MP0008775_abnormal_heart_ventricle | 0.66145444 |
| 96 | MP0000685_abnormal_immune_system | 0.66110331 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.66097417 |
| 98 | MP0005423_abnormal_somatic_nervous | 0.65863140 |
| 99 | MP0005408_hypopigmentation | 0.65806671 |
| 100 | MP0005000_abnormal_immune_tolerance | 0.65165246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.64685503 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.14846962 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.96835552 |
| 4 | Acute encephalopathy (HP:0006846) | 4.94653127 |
| 5 | Progressive macrocephaly (HP:0004481) | 4.65701488 |
| 6 | Increased CSF lactate (HP:0002490) | 4.54224581 |
| 7 | Increased hepatocellular lipid droplets (HP:0006565) | 4.41359520 |
| 8 | Hepatocellular necrosis (HP:0001404) | 4.35087494 |
| 9 | Lipid accumulation in hepatocytes (HP:0006561) | 4.19380511 |
| 10 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.04126302 |
| 11 | Hepatic necrosis (HP:0002605) | 3.88290049 |
| 12 | Cerebral edema (HP:0002181) | 3.70726352 |
| 13 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.56694593 |
| 14 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.56694593 |
| 15 | Renal Fanconi syndrome (HP:0001994) | 3.56350102 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.52043008 |
| 17 | Reticulocytopenia (HP:0001896) | 3.41900812 |
| 18 | Exertional dyspnea (HP:0002875) | 3.27684132 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.25919376 |
| 20 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.19300621 |
| 21 | Increased serum lactate (HP:0002151) | 3.14670534 |
| 22 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.13116735 |
| 23 | Macrocytic anemia (HP:0001972) | 3.08662730 |
| 24 | 3-Methylglutaconic aciduria (HP:0003535) | 3.03689412 |
| 25 | Optic disc pallor (HP:0000543) | 3.03685650 |
| 26 | Increased muscle lipid content (HP:0009058) | 3.01318768 |
| 27 | Lactic acidosis (HP:0003128) | 2.82213284 |
| 28 | Abnormal number of erythroid precursors (HP:0012131) | 2.75674505 |
| 29 | Respiratory failure (HP:0002878) | 2.74569301 |
| 30 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.72645540 |
| 31 | Molar tooth sign on MRI (HP:0002419) | 2.72361286 |
| 32 | Abnormality of midbrain morphology (HP:0002418) | 2.72361286 |
| 33 | Pendular nystagmus (HP:0012043) | 2.68293976 |
| 34 | Leukodystrophy (HP:0002415) | 2.63658850 |
| 35 | Pallor (HP:0000980) | 2.63599909 |
| 36 | Exercise intolerance (HP:0003546) | 2.60805192 |
| 37 | Pancreatic cysts (HP:0001737) | 2.58140967 |
| 38 | Lethargy (HP:0001254) | 2.52537754 |
| 39 | Congenital stationary night blindness (HP:0007642) | 2.51612350 |
| 40 | Type II lissencephaly (HP:0007260) | 2.50984806 |
| 41 | Respiratory difficulties (HP:0002880) | 2.48489497 |
| 42 | Decreased central vision (HP:0007663) | 2.47981350 |
| 43 | Pancreatic fibrosis (HP:0100732) | 2.41699722 |
| 44 | Hyperglycinemia (HP:0002154) | 2.39794704 |
| 45 | Type 2 muscle fiber atrophy (HP:0003554) | 2.38343489 |
| 46 | True hermaphroditism (HP:0010459) | 2.31620872 |
| 47 | Abolished electroretinogram (ERG) (HP:0000550) | 2.28670569 |
| 48 | Nephronophthisis (HP:0000090) | 2.26849513 |
| 49 | Abnormality of renal resorption (HP:0011038) | 2.21318064 |
| 50 | Muscle fiber atrophy (HP:0100295) | 2.20552164 |
| 51 | Aplastic anemia (HP:0001915) | 2.19442429 |
| 52 | Attenuation of retinal blood vessels (HP:0007843) | 2.18325157 |
| 53 | Constricted visual fields (HP:0001133) | 2.13914129 |
| 54 | CNS demyelination (HP:0007305) | 2.12230297 |
| 55 | Glycosuria (HP:0003076) | 2.07277688 |
| 56 | Abnormality of urine glucose concentration (HP:0011016) | 2.07277688 |
| 57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.05840490 |
| 58 | Abnormality of DNA repair (HP:0003254) | 2.05015359 |
| 59 | IgG deficiency (HP:0004315) | 2.04763016 |
| 60 | Hyperphosphaturia (HP:0003109) | 2.00979010 |
| 61 | Absent thumb (HP:0009777) | 1.98916604 |
| 62 | Methylmalonic acidemia (HP:0002912) | 1.97055674 |
| 63 | Methylmalonic aciduria (HP:0012120) | 1.91624373 |
| 64 | Dyschromatopsia (HP:0007641) | 1.89974891 |
| 65 | Medial flaring of the eyebrow (HP:0010747) | 1.89209136 |
| 66 | X-linked dominant inheritance (HP:0001423) | 1.88762912 |
| 67 | Colon cancer (HP:0003003) | 1.86848323 |
| 68 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.85274436 |
| 69 | Hypoproteinemia (HP:0003075) | 1.82443374 |
| 70 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81440077 |
| 71 | Triphalangeal thumb (HP:0001199) | 1.80404243 |
| 72 | Myokymia (HP:0002411) | 1.79513942 |
| 73 | Emotional lability (HP:0000712) | 1.79406945 |
| 74 | Severe combined immunodeficiency (HP:0004430) | 1.79261802 |
| 75 | Keratoconus (HP:0000563) | 1.78089142 |
| 76 | Increased corneal curvature (HP:0100692) | 1.78089142 |
| 77 | Testicular atrophy (HP:0000029) | 1.76398200 |
| 78 | Blindness (HP:0000618) | 1.75864745 |
| 79 | Cerebellar dysplasia (HP:0007033) | 1.75835980 |
| 80 | Cerebral hypomyelination (HP:0006808) | 1.75695412 |
| 81 | Chronic hepatic failure (HP:0100626) | 1.74063973 |
| 82 | Abnormality of the renal medulla (HP:0100957) | 1.73469630 |
| 83 | Hypoplasia of the pons (HP:0012110) | 1.72527079 |
| 84 | Sclerocornea (HP:0000647) | 1.71862707 |
| 85 | Cleft eyelid (HP:0000625) | 1.70459494 |
| 86 | Stenosis of the external auditory canal (HP:0000402) | 1.68366990 |
| 87 | Asplenia (HP:0001746) | 1.67829079 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.67726649 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 1.67726649 |
| 90 | Abnormality of the pons (HP:0007361) | 1.66658195 |
| 91 | Polyuria (HP:0000103) | 1.65475791 |
| 92 | Abnormal drinking behavior (HP:0030082) | 1.63727940 |
| 93 | Polydipsia (HP:0001959) | 1.63727940 |
| 94 | Abnormality of B cell number (HP:0010975) | 1.62134288 |
| 95 | Abnormality of the renal cortex (HP:0011035) | 1.62095972 |
| 96 | Abnormality of the labia minora (HP:0012880) | 1.60467693 |
| 97 | CNS hypomyelination (HP:0003429) | 1.60364430 |
| 98 | Abnormality of alanine metabolism (HP:0010916) | 1.59508360 |
| 99 | Hyperalaninemia (HP:0003348) | 1.59508360 |
| 100 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.59508360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 3.11157747 |
| 2 | CDK19 | 2.95674429 |
| 3 | NME2 | 2.86720409 |
| 4 | BCKDK | 2.74309156 |
| 5 | TAOK3 | 2.59947349 |
| 6 | VRK2 | 2.55971051 |
| 7 | TLK1 | 2.51768967 |
| 8 | STK16 | 2.50613618 |
| 9 | NUAK1 | 2.44114267 |
| 10 | MAP4K2 | 2.32097183 |
| 11 | ADRBK2 | 2.29541284 |
| 12 | MST4 | 2.25221213 |
| 13 | GRK1 | 2.04081314 |
| 14 | WNK4 | 1.85162692 |
| 15 | TIE1 | 1.84560240 |
| 16 | VRK1 | 1.61413989 |
| 17 | INSRR | 1.59097823 |
| 18 | MAP3K12 | 1.57207339 |
| 19 | NEK1 | 1.55990058 |
| 20 | KDR | 1.55510013 |
| 21 | EIF2AK3 | 1.55417840 |
| 22 | TXK | 1.55325326 |
| 23 | BMPR1B | 1.55257944 |
| 24 | DYRK2 | 1.49343971 |
| 25 | OXSR1 | 1.47349609 |
| 26 | TEC | 1.40024082 |
| 27 | WNK3 | 1.38264118 |
| 28 | CDC7 | 1.36569366 |
| 29 | PINK1 | 1.19197060 |
| 30 | MAP4K1 | 1.16576426 |
| 31 | CDK8 | 1.11450191 |
| 32 | LIMK1 | 1.10608903 |
| 33 | MAP3K11 | 1.09342794 |
| 34 | FRK | 1.06966491 |
| 35 | PASK | 1.05501095 |
| 36 | DAPK1 | 0.93928705 |
| 37 | KIT | 0.93745205 |
| 38 | AURKA | 0.90096908 |
| 39 | PLK4 | 0.88554663 |
| 40 | PLK1 | 0.88283793 |
| 41 | MAPKAPK5 | 0.86382987 |
| 42 | TRIM28 | 0.85238742 |
| 43 | SRPK1 | 0.85102052 |
| 44 | CAMKK2 | 0.85092148 |
| 45 | FES | 0.83319341 |
| 46 | MAP2K7 | 0.82796122 |
| 47 | MYLK | 0.81948483 |
| 48 | PRKCQ | 0.80335971 |
| 49 | CSNK1G3 | 0.78688830 |
| 50 | STK39 | 0.75919324 |
| 51 | BUB1 | 0.75649922 |
| 52 | ATR | 0.74115232 |
| 53 | RPS6KA5 | 0.74020976 |
| 54 | MAPKAPK3 | 0.73822460 |
| 55 | MAPK13 | 0.73614111 |
| 56 | CSNK2A2 | 0.72203890 |
| 57 | DAPK3 | 0.71051704 |
| 58 | ABL2 | 0.70937864 |
| 59 | DAPK2 | 0.70857795 |
| 60 | ITK | 0.69798274 |
| 61 | SCYL2 | 0.67787253 |
| 62 | CSNK1G2 | 0.66633897 |
| 63 | MAP3K4 | 0.66137232 |
| 64 | PLK3 | 0.64139815 |
| 65 | STK3 | 0.63790574 |
| 66 | MAP2K6 | 0.63715200 |
| 67 | CSNK2A1 | 0.63188912 |
| 68 | IKBKB | 0.63146964 |
| 69 | SYK | 0.61740532 |
| 70 | MATK | 0.60638370 |
| 71 | CASK | 0.58072715 |
| 72 | NEK2 | 0.54791817 |
| 73 | PRKCG | 0.54751705 |
| 74 | PRKACA | 0.54245022 |
| 75 | ADRBK1 | 0.54150012 |
| 76 | TNK2 | 0.53502051 |
| 77 | OBSCN | 0.53218972 |
| 78 | AURKB | 0.53185376 |
| 79 | FLT3 | 0.51211284 |
| 80 | PIK3CA | 0.50493256 |
| 81 | CSNK1A1L | 0.50384543 |
| 82 | GRK6 | 0.49212386 |
| 83 | TESK2 | 0.49183599 |
| 84 | CSNK1G1 | 0.49094862 |
| 85 | PBK | 0.49056401 |
| 86 | PHKG1 | 0.48156068 |
| 87 | PHKG2 | 0.48156068 |
| 88 | TGFBR1 | 0.47408607 |
| 89 | ILK | 0.47137070 |
| 90 | CSNK1A1 | 0.44337246 |
| 91 | PRKCA | 0.43666664 |
| 92 | PDK2 | 0.42862042 |
| 93 | LRRK2 | 0.42669067 |
| 94 | MARK3 | 0.42538261 |
| 95 | NME1 | 0.42345445 |
| 96 | MKNK1 | 0.41374673 |
| 97 | PIM1 | 0.40752664 |
| 98 | MINK1 | 0.39658282 |
| 99 | LYN | 0.39536090 |
| 100 | CHEK2 | 0.38526083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.74832295 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.14663798 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.50369955 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.32026978 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.85052843 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.74858045 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.67548486 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.35531094 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.27209780 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.25698407 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.21343212 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.11831453 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.03189358 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01620852 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.97077727 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.84760573 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.75105985 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.70071707 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.64555046 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.62177960 |
| 21 | RNA degradation_Homo sapiens_hsa03018 | 1.56223010 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.53314401 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.46779075 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.44466364 |
| 25 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.33170113 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.31925808 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.28164315 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.27215312 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.23367777 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20246323 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20209296 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.17874387 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.16433371 |
| 34 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16151930 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.11886788 |
| 36 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.10874293 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08427966 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07745768 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01105696 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.00775204 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00239338 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96212983 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 0.95737782 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94344065 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92706155 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92379943 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 0.91723337 |
| 48 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.90072896 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 0.89354705 |
| 50 | RNA transport_Homo sapiens_hsa03013 | 0.88912668 |
| 51 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.82693322 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81859544 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80131249 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77071659 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74995398 |
| 56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73740253 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73700777 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73078001 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71096713 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70189850 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69626444 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69501723 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69086412 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65411908 |
| 65 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64957483 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62960835 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62282477 |
| 68 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61294751 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60409649 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60371565 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60236350 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59484244 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58934240 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56952593 |
| 75 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54277655 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51949116 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50568417 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50252052 |
| 79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.49095260 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48929130 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47652092 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46094838 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45339731 |
| 84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45333813 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43733433 |
| 86 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43201385 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.42813559 |
| 88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42722376 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40440194 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40245520 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39921052 |
| 92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35440297 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33640247 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32181521 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24590314 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.22176229 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.21276264 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.20698526 |
| 99 | Leishmaniasis_Homo sapiens_hsa05140 | 0.19964751 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.17409483 |

